Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 6/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 11/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12428121 | 0.84 | KAT8 (0.45) | EP300KAT8MAPTL3MBTL1SMN1; SMN2 | |
| SCHEMBL12428202 | 0.84 | KAT8 (0.43) | KAT8MAPTL3MBTL1SMN1; SMN2MEN1 | |
| SCHEMBL12428249 | 0.83 | EP300 (0.41) | EP300KAT8SCN9AMAPTL3MBTL1 | |
| SCHEMBL12428248 | 0.83 | SIRT5 (0.47) | EP300MAPTL3MBTL1MEN1ALDH1A1 | |
| SCHEMBL12428261 | 0.82 | EP300 (0.40) | EP300KAT8SCN9AMAPTL3MBTL1 | |
| SCHEMBL12428264 | 0.82 | EP300 (0.40) | EP300KAT8SCN9AMAPTL3MBTL1 | |
| SCHEMBL12428446 | 0.82 | MEN1 (0.42) | KAT8SCN9AMAPTL3MBTL1MAPK1 | |
| SCHEMBL12428447 | 0.82 | MEN1 (0.42) | KAT8SCN9AMAPTL3MBTL1MAPK1 | |
| SCHEMBL12428273 | 0.81 | SCN9A (0.36) | EP300KAT8SCN9AMAPTL3MBTL1 | |
| SCHEMBL12428192 | 0.81 | KAT8 (0.43) | KAT8MAPTL3MBTL1SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977570-B2 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977570-B2 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-04-02 | — | — | US | disclosed |
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-04-02 | — | — | US | disclosed |
| EP-1885015-A1 | DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE | Nippon Kayaku Kabushiki Kaisha (JP) | 2008-02-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | CRY1, H1-5, H1-0 | EP300 2442/4885KAT8 1908/4885SCN9A 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.